Updated:
Mediq
Mediq began in 1899 as a Dutch pharmacists' cooperative, spending more than a century building distribution relationships before Advent International acquired...
Mediq
Mediq began in 1899 as a Dutch pharmacists' cooperative, spending more than a century building distribution relationships before Advent International acquired and delisted the company in 2013. Under Advent's ownership the group supplies medical consumables, devices, and homecare products across 14 European countries, with its modern operational center in Utrecht and satellite offices in the United Kingdom and Lithuania. Advent operates Mediq as a direct investor through two tracks: balance-sheet M&A that expands its distribution footprint—the April 2024 acquisition of Ireland's Medguard Healthcare is the latest example—and MediqVentures, a structured corporate venture arm co-founded with biotech entrepreneurs Jim Mellon, Gregory Bailey, and Declan Doogan. MediqVentures targets early-stage European and Israeli health-tech companies developing products that can move through Mediq's own logistics network, giving the firm a proprietary sourcing lane that generic financial buyers cannot replicate. Mediq does not disclose assets under management or total deployment. The group reports its ESG metrics annually through a proprietary framework organized around products, services, operations, and people, with a public target of carbon neutrality by 2050. Adjacent vehicles include MEDIQ Financial Services in Australia, a wealth management firm owned by Focus Financial Partners that operates under the same brand name but is structurally separate from the European distribution business. In April 2024 Mediq consolidated its own-brand medical products under the single label Mediq Select, a streamlining move that signals further integration of its supply chain ahead of potential portfolio expansion. Mediq's structural differentiator is its corporate-venture hybrid model: a private-equity-backed operating company that uses its own procurement and logistics infrastructure to diligence and distribute the products of its venture investments. The MediqVentures relationship embeds three external biotech founders into the deal-sourcing process, giving Advent an early look at technologies that can be stress-tested inside Mediq's existing hospital contracts before broader commercial rollout.
General information
Firm type
Corporate Investor
Year founded
1899
AUM
Undisclosed
Location
Region
Europe
Country
Netherlands
City
Utrecht
Corporate office
Hertogswetering 159, Utrecht, Netherlands
Additional offices
Castle Donington, United Kingdom · Cheshunt, United Kingdom · Vilnius, Lithuania
Sector focus
Frequently asked questions
Who co-founded MediqVentures and how does it source deals?
MediqVentures was co-founded by biotech investors Jim Mellon, Gregory Bailey, and Declan Doogan alongside Mediq's private equity owner, Advent International. The group invests in early-stage health-tech companies based in Europe and Israel, using Mediq's existing distribution network to diligence and scale portfolio products. This gives MediqVentures a sourcing advantage: startups gain immediate access to a 14-country logistics platform, while Mediq gets an early look at technologies that can move through its own hospital contracts.
Is Mediq structured as a family office or a corporate investor?
Mediq is a corporate investor controlled by private equity firm Advent International, which took the company private in 2013. It operates a direct M&A strategy to acquire complementary healthcare distributors across Europe and a separate corporate venture arm, MediqVentures, for early-stage health-tech deals. The group does not manage third-party capital or operate as a multi-family office.
What is Mediq's relationship with MEDIQ Financial Services in Australia?
MEDIQ Financial Services is a wealth management firm in Australia owned by Focus Financial Partners. Despite the shared brand name, it is structurally separate from Mediq's European distribution and corporate venture activities and does not represent a financial-services expansion of the Dutch parent company.
What sustainability commitments has Mediq made?
Mediq published its 2025 ESG Report outlining progress toward carbon neutrality by 2050, with digitalization and supply-chain optimization as core drivers. The firm's ESG framework is built around products, services, operations, and people, and includes case studies on nutrition care in Denmark and incontinence-care logistics in nursing homes. These commitments are reported alongside Advent International's broader portfolio-level ESG reporting.
Which geographic markets does Mediq serve?
Mediq operates in 14 European countries, with an owned logistics and distribution network that includes headquarters in the Netherlands, multiple offices in the United Kingdom, and a business services center in Vilnius, Lithuania. The 2024 acquisition of Medguard Healthcare extended the group's physical presence into Ireland, and MediqVentures draws deal flow from both Western Europe and Israel.
Does Mediq participate in fund commitments or only direct deals?
Mediq's capital deployment follows two direct paths: corporate M&A for distribution-scale acquisitions and MediqVentures for direct equity stakes in early-stage health-tech companies. There is no public evidence that the firm makes fund commitments or acts as a limited partner in third-party venture or private equity funds.
Who runs investment decisions at Mediq?
Mediq does not publicly name a CIO or head of investments. Its corporate M&A strategy is executed under Advent International's control, while MediqVentures' investment decisions involve co-founders Jim Mellon, Gregory Bailey, and Declan Doogan. Day-to-day operating leadership for the distribution business is not disclosed on the firm's public website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: